Briefs

KINGSTON, Ontario & MONTREAL--(BUSINESS WIRE)--June 21, 2004--

BIOSYSTEMIX PROVIDES ADVANCED DATA MINING AND PREDICTIVE MODELING AS AN S2K PROGRAM PARTNER FOR THE DEVELOPMENT OF PERSONALIZED MEDICINE MODELS IN IMMUNE DISEASES

Biosystemix (www.biosystemix.com) joins S2K (www.s2kgenome.ca) as partner to develop data-driven computational models that predict disease susceptibility and progression, and therapeutic response. Funded by Genome Canada and Genome Quebec, S2K's program, "Functional Genomics, Pharmacogenomics and Proteomics of the Immune Response in Health and Immune Related Disorders," brings leading experts, institutions, and private sector efforts into a significant partnership to advance fundamental scientific understanding of immune dysfunction, and generate intellectual property for effective diagnostic and therapeutic agents including vaccines.

Biosystemix employs field-advancing data mining algorithms to discover complex relationships that link predictive marker sets to critical clinical outcomes and phenotypes. "The complexity of the immunological response often involves the combined action of multiple cellular and molecular effectors," explains Dr. Larry Greller, CSO of Biosystemix. "Our pattern analysis methods capture the combinatorial and nonlinear relationships required for the effective discovery of these complex disease markers and mechanistic regulators."

Here is the rest of the story.